Research / PLTR / Fundamental state Inspectable configuration
State dimensions Filing 0001321655-22-000032 General Corporate
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
3.02% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
9.85% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
21.86% · CORE · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
77.48% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
-13.01% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
21.11% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
29.36% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 23 states Self-history eligible
Sep 30, 2021 0/6 normalized Level 3 Dec 31, 2021 0/7 normalized Level 3 Mar 31, 2022 0/7 normalized Level 3 Jun 30, 2022 0/7 normalized Level 3 Sep 30, 2022 0/7 normalized Level 3 Dec 31, 2022 6/7 normalized Level 3 Mar 31, 2023 6/7 normalized Level 3 Jun 30, 2023 6/7 normalized Level 3 Sep 30, 2023 6/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 1.15%
Current 3.02%
Delta 1.87% Cash Generation Decreased
Previous 13.20%
Current 9.85%
Delta -3.35% Growth Decreased
Previous 25.92%
Current 21.86%
Delta -4.06% Margin Decreased
Previous 78.39%
Current 77.48%
Delta -0.91% Profitability Decreased
Previous -8.83%
Current -13.01%
Delta -4.19% R And D Intensity Increased
Previous 18.64%
Current 21.11%
Delta 2.47% Sbc Intensity Decreased
Previous 30.82%
Current 29.36%
Delta -1.46% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.